Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Jitters jeopardize AIDS vaccine trials.

× No keyword cloud information.

26 in total

1. A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B.

Authors: J P Moore; A Trkola; B Korber; L J Boots; J A Kessler; F E McCutchan; J Mascola; D D Ho; J Robinson; A J Conley
Journal: J Virol Date: 1995-01 Impact factor: 5.103

2. Induction and characterization of neutralizing antibodies against a human immunodeficiency virus type 1 primary isolate.

Authors: C H Chen; L Jin; C Zhu; S Holz-Smith; T J Matthews
Journal: J Virol Date: 2001-07 Impact factor: 5.103

3. The V3-directed immune response in natural human immunodeficiency virus type 1 infection is predominantly directed against a variable, discontinuous epitope presented by the gp120 V3 domain.

Authors: M Schreiber; C Wachsmuth; H Müller; S Odemuyiwa; H Schmitz; S Meyer; B Meyer; J Schneider-Mergener
Journal: J Virol Date: 1997-12 Impact factor: 5.103

4. Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope.

Authors: J Richardson; A Moraillon; S Baud; A M Cuisinier; P Sonigo; G Pancino
Journal: J Virol Date: 1997-12 Impact factor: 5.103

5. Macrophage-tropic and T-cell line-adapted chimeric strains of human immunodeficiency virus type 1 differ in their susceptibilities to neutralization by soluble CD4 at different temperatures.

Authors: W A O'Brien; S H Mao; Y Cao; J P Moore
Journal: J Virol Date: 1994-08 Impact factor: 5.103

Review 6. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors: M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal: Clin Microbiol Rev Date: 1995-01 Impact factor: 26.132

7. Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin molecules.

Authors: M C Gauduin; G P Allaway; P J Maddon; C F Barbas; D R Burton; R A Koup
Journal: J Virol Date: 1996-04 Impact factor: 5.103

8. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system.

Authors: F Baldinotti; D Matteucci; P Mazzetti; C Giannelli; P Bandecchi; F Tozzini; M Bendinelli
Journal: J Virol Date: 1994-07 Impact factor: 5.103

9. Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: investigation of the mechanism of inhibition.

Authors: C Spenlehauer; A Kirn; A M Aubertin; C Moog
Journal: J Virol Date: 2001-03 Impact factor: 5.103

10. Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes.

Authors: J P Moore; Y Cao; J Leu; L Qin; B Korber; D D Ho
Journal: J Virol Date: 1996-01 Impact factor: 5.103